Unax Lertxundi, Arantxazu Isla, Maria Angeles Solinis, Saioa Domingo-Echaburu, Rafael Hernandez, Javier Peral-Aguirregoitia, Juan Medrano
PURPOSE: Anticholinergic toxicity can arise as a result of the cumulative burden of multiple medications and metabolites rather than be caused by a single compound. In this sense, prescribing drugs with anticholinergic properties to Parkinson's disease (PD) patients could contribute to aggravate some frequent problems of the disease, like dementia, urinary retention, falls, or constipation, among others. The main purpose of this article is to measure the total anticholinergic burden in a group of PD inpatients...
October 2015: European Journal of Clinical Pharmacology